Padmini Giri

2.6k total citations · 1 hit paper
11 papers, 1.9k citations indexed

About

Padmini Giri is a scholar working on Infectious Diseases, Oncology and Molecular Biology. According to data from OpenAlex, Padmini Giri has authored 11 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Padmini Giri's work include Lung Cancer Research Studies (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Padmini Giri is often cited by papers focused on Lung Cancer Research Studies (4 papers), COVID-19 Clinical Research Studies (3 papers) and Long-Term Effects of COVID-19 (3 papers). Padmini Giri collaborates with scholars based in United States. Padmini Giri's co-authors include Michael LeBlanc, T. Vuong, Dorit Elisabeth Schuller, K.K. Fu, George L. Adams, Wael Sakr, Muhyi Al‐Sarraf, Jay S. Cooper, John F. Ensley and A A Forastiere and has published in prestigious journals such as Journal of Clinical Oncology, CHEST Journal and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Padmini Giri

10 papers receiving 1.9k citations

Hit Papers

Chemoradiotherapy versus radiotherapy in patients with ad... 1998 2026 2007 2016 1998 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Padmini Giri United States 6 1.4k 1.1k 911 590 195 11 1.9k
A A Forastiere United States 9 1.5k 1.1× 1.1k 1.1× 911 1.0× 605 1.0× 232 1.2× 14 2.0k
Sing Fai Leung Hong Kong 21 1.6k 1.1× 1.1k 1.1× 1.1k 1.2× 712 1.2× 366 1.9× 41 2.4k
T. Vuong Canada 6 1.4k 1.0× 1.1k 1.0× 776 0.9× 532 0.9× 137 0.7× 10 1.7k
Fred Rosen United States 13 846 0.6× 556 0.5× 669 0.7× 570 1.0× 241 1.2× 22 1.3k
A. Dekker United States 17 638 0.4× 314 0.3× 710 0.8× 551 0.9× 410 2.1× 38 1.3k
Samy El‐Sayed Canada 8 733 0.5× 528 0.5× 276 0.3× 409 0.7× 109 0.6× 14 1.2k
Ellie Maghami United States 17 457 0.3× 359 0.3× 525 0.6× 396 0.7× 303 1.6× 50 1.3k
Carlo Gobitti Italy 16 363 0.3× 266 0.3× 369 0.4× 507 0.9× 70 0.4× 55 994
Tomasz Rutkowski Poland 17 419 0.3× 247 0.2× 260 0.3× 358 0.6× 233 1.2× 102 981

Countries citing papers authored by Padmini Giri

Since Specialization
Citations

This map shows the geographic impact of Padmini Giri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Padmini Giri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Padmini Giri more than expected).

Fields of papers citing papers by Padmini Giri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Padmini Giri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Padmini Giri. The network helps show where Padmini Giri may publish in the future.

Co-authorship network of co-authors of Padmini Giri

This figure shows the co-authorship network connecting the top 25 collaborators of Padmini Giri. A scholar is included among the top collaborators of Padmini Giri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Padmini Giri. Padmini Giri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Al‐Sarraf, Muhyi, Michael LeBlanc, Padmini Giri, et al.. (2023). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.. Journal of Clinical Oncology. 41(24). 3965–3972. 6 indexed citations
2.
Giri, Padmini, et al.. (2021). METABOLIC EMERGENCIES IN THE WORLD OF COVID: HHS/DKA AND ACUTE SEVERE PANCREATITIS. CHEST Journal. 160(4). A892–A893. 1 indexed citations
3.
Giri, Padmini, et al.. (2020). COVID ENCEPHALOPATHY IN THE SETTING OF MULTIPLE BILATERAL ACUTE CEREBRAL VASCULAR INFARCTS. CHEST Journal. 158(4). A890–A890. 3 indexed citations
4.
Patel, Manishkumar, et al.. (2020). THE SIGNIFICANCE OF ORAL ASCORBIC ACID IN PATIENTS WITH COVID-19. CHEST Journal. 158(4). A325–A325. 6 indexed citations
5.
Giri, Padmini, et al.. (2020). SUDDEN CARDIAC DEATH AND THE PECULIAR COVID-19 CASE. CHEST Journal. 158(4). A271–A271.
6.
Patel, Manishkumar, et al.. (2020). CORTICOSTEROID TREATMENT IN PATIENTS WITH SEVERE COVID-19 PNEUMONIA. CHEST Journal. 158(4). A599–A599. 3 indexed citations
7.
Britten, Richard A., et al.. (2005). Identification of reproducible low mass SELDI protein profiles specific to cisplatin resistance in human ovarian cancer cells. Oncology Reports. 14(5). 1323–30. 15 indexed citations
8.
Thomas, Charles R., Dorothy J. Giroux, Andrew T. Turrisi, et al.. (2001). Ten-year follow-up of Southwest Oncology Group 8269: a phase II trial of concomitant cisplatin–etoposide and daily thoracic radiotherapy in limited small-cell lung cancer. Lung Cancer. 33(2-3). 213–219. 20 indexed citations
9.
Al‐Sarraf, Muhyi, Michael LeBlanc, Padmini Giri, et al.. (1998). Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099.. Journal of Clinical Oncology. 16(4). 1310–1317. 1695 indexed citations breakdown →
10.
McCracken, Joseph D., John J. Crowley, Padmini Giri, et al.. (1990). Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a Southwest Oncology Group Study.. Journal of Clinical Oncology. 8(5). 892–898. 138 indexed citations
11.
McCracken, Joseph D., et al.. (1987). Concommittant chemo radiotherapy in limited smallcell carcinoma of lung: Improved response and median survival. A southwest oncology group study. International Journal of Radiation Oncology*Biology*Physics. 13. 188–188. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026